Flip Therapeutics

Seed
fliptx.bio Biotech & Healthcare London, United Kingdom
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Sep 3, 2026
Investors 1 Backer
Decision Makers 2 Verified

About Flip Therapeutics

Flip Therapeutics develops in vivo immune cell reprogramming therapies for chronic autoimmune and inflammatory diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters London, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website fliptx.bio
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

1
Medicines Discovery Catapult

Funding History

1 Round
Seed · Sep 3, 2026
Undisclosed

Founders & Leadership

3

Anis Gammage

Co-Founder

Work email & phone locked Unlock →

Dave Pajerowski

Co-Founder, CEO & Head of Technology

Work email & phone locked Unlock →

Mathias Pawlak

Co-Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts